nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxandrolone—AR—prostate cancer	0.224	1	CbGaD
Oxandrolone—AR—Bicalutamide—prostate cancer	0.108	0.315	CbGbCtD
Oxandrolone—AR—Nilutamide—prostate cancer	0.108	0.315	CbGbCtD
Oxandrolone—AR—Flutamide—prostate cancer	0.0895	0.261	CbGbCtD
Oxandrolone—Testosterone—Abiraterone—prostate cancer	0.0484	0.153	CrCrCtD
Oxandrolone—Trilostane—Estradiol—prostate cancer	0.0412	0.13	CrCrCtD
Oxandrolone—AR—Estradiol—prostate cancer	0.0372	0.108	CbGbCtD
Oxandrolone—Formestane—Estrone—prostate cancer	0.0329	0.104	CrCrCtD
Oxandrolone—Drostanolone—Estradiol—prostate cancer	0.0298	0.0943	CrCrCtD
Oxandrolone—Formestane—Conjugated Estrogens—prostate cancer	0.0289	0.0916	CrCrCtD
Oxandrolone—Testosterone Propionate—Estradiol valerate/Dienogest—prostate cancer	0.0272	0.0862	CrCrCtD
Oxandrolone—Testosterone—Estramustine—prostate cancer	0.0201	0.0636	CrCrCtD
Oxandrolone—Danazol—Ethinyl Estradiol—prostate cancer	0.0186	0.0588	CrCrCtD
Oxandrolone—Norethindrone—Ethinyl Estradiol—prostate cancer	0.0161	0.0512	CrCrCtD
Oxandrolone—Testosterone—Estrone—prostate cancer	0.016	0.0506	CrCrCtD
Oxandrolone—Methyltestosterone—Ethinyl Estradiol—prostate cancer	0.0133	0.042	CrCrCtD
Oxandrolone—Testosterone—Estradiol—prostate cancer	0.0121	0.0383	CrCrCtD
Oxandrolone—Danazol—Prednisone—prostate cancer	0.00652	0.0207	CrCrCtD
Oxandrolone—AR—penis—prostate cancer	0.00569	0.325	CbGeAlD
Oxandrolone—AR—semen—prostate cancer	0.00542	0.31	CbGeAlD
Oxandrolone—Testicular atrophy—Nilutamide—prostate cancer	0.00488	0.0797	CcSEcCtD
Oxandrolone—Methyltestosterone—Prednisone—prostate cancer	0.00466	0.0148	CrCrCtD
Oxandrolone—Testicular atrophy—Degarelix—prostate cancer	0.00436	0.0712	CcSEcCtD
Oxandrolone—Glucose tolerance decreased—Estramustine—prostate cancer	0.00397	0.0649	CcSEcCtD
Oxandrolone—Glucose tolerance decreased—Conjugated Estrogens—prostate cancer	0.00175	0.0287	CcSEcCtD
Oxandrolone—Glucose tolerance decreased—Estradiol—prostate cancer	0.0014	0.0229	CcSEcCtD
Oxandrolone—Bronchial hyperreactivity—Goserelin—prostate cancer	0.00136	0.0223	CcSEcCtD
Oxandrolone—AR—prostate gland—prostate cancer	0.00136	0.0777	CbGeAlD
Oxandrolone—Hirsutism—Estrone—prostate cancer	0.00131	0.0214	CcSEcCtD
Oxandrolone—Chronic obstructive pulmonary disease—Goserelin—prostate cancer	0.00124	0.0203	CcSEcCtD
Oxandrolone—Hepatic necrosis—Flutamide—prostate cancer	0.00121	0.0198	CcSEcCtD
Oxandrolone—AR—seminal vesicle—prostate cancer	0.00115	0.0657	CbGeAlD
Oxandrolone—Hirsutism—Estradiol valerate/Dienogest—prostate cancer	0.00114	0.0187	CcSEcCtD
Oxandrolone—AR—epithelium—prostate cancer	0.000998	0.0571	CbGeAlD
Oxandrolone—AR—renal system—prostate cancer	0.000926	0.053	CbGeAlD
Oxandrolone—AR—urethra—prostate cancer	0.000909	0.052	CbGeAlD
Oxandrolone—Hirsutism—Bicalutamide—prostate cancer	0.000879	0.0144	CcSEcCtD
Oxandrolone—Jaundice cholestatic—Estrone—prostate cancer	0.000867	0.0142	CcSEcCtD
Oxandrolone—Jaundice cholestatic—Flutamide—prostate cancer	0.000802	0.0131	CcSEcCtD
Oxandrolone—Acne—Estradiol valerate/Dienogest—prostate cancer	0.00079	0.0129	CcSEcCtD
Oxandrolone—Glucose tolerance decreased—Prednisone—prostate cancer	0.00078	0.0127	CcSEcCtD
Oxandrolone—Jaundice cholestatic—Estradiol valerate/Dienogest—prostate cancer	0.000757	0.0124	CcSEcCtD
Oxandrolone—Creatinine increased—Nilutamide—prostate cancer	0.000743	0.0121	CcSEcCtD
Oxandrolone—Fluid retention—Abiraterone—prostate cancer	0.000735	0.012	CcSEcCtD
Oxandrolone—Gynaecomastia—Estramustine—prostate cancer	0.000714	0.0117	CcSEcCtD
Oxandrolone—Neoplasm—Flutamide—prostate cancer	0.000637	0.0104	CcSEcCtD
Oxandrolone—Gynaecomastia—Nilutamide—prostate cancer	0.000633	0.0103	CcSEcCtD
Oxandrolone—Gynaecomastia—Flutamide—prostate cancer	0.00063	0.0103	CcSEcCtD
Oxandrolone—Hirsutism—Goserelin—prostate cancer	0.000612	0.00999	CcSEcCtD
Oxandrolone—Hirsutism—Conjugated Estrogens—prostate cancer	0.000606	0.0099	CcSEcCtD
Oxandrolone—AR—testis—prostate cancer	0.000598	0.0342	CbGeAlD
Oxandrolone—Oligospermia—Epirubicin—prostate cancer	0.000584	0.00955	CcSEcCtD
Oxandrolone—Gynaecomastia—Degarelix—prostate cancer	0.000566	0.00924	CcSEcCtD
Oxandrolone—Oligospermia—Doxorubicin—prostate cancer	0.00054	0.00883	CcSEcCtD
Oxandrolone—Creatinine increased—Bicalutamide—prostate cancer	0.000537	0.00877	CcSEcCtD
Oxandrolone—Trilostane—HSD3B1—prostate cancer	0.000535	0.169	CrCbGaD
Oxandrolone—Irritability—Estrone—prostate cancer	0.000528	0.00863	CcSEcCtD
Oxandrolone—Acne—Ethinyl Estradiol—prostate cancer	0.000513	0.00839	CcSEcCtD
Oxandrolone—Menstruation irregular—Estradiol—prostate cancer	0.000509	0.00832	CcSEcCtD
Oxandrolone—Hirsutism—Estradiol—prostate cancer	0.000485	0.00792	CcSEcCtD
Oxandrolone—Blood creatinine increased—Nilutamide—prostate cancer	0.000481	0.00786	CcSEcCtD
Oxandrolone—Neoplasm—Bicalutamide—prostate cancer	0.000462	0.00755	CcSEcCtD
Oxandrolone—Erectile dysfunction—Estramustine—prostate cancer	0.000461	0.00753	CcSEcCtD
Oxandrolone—Irritability—Estradiol valerate/Dienogest—prostate cancer	0.000461	0.00753	CcSEcCtD
Oxandrolone—Gynaecomastia—Bicalutamide—prostate cancer	0.000457	0.00747	CcSEcCtD
Oxandrolone—Azoospermia—Epirubicin—prostate cancer	0.000454	0.00743	CcSEcCtD
Oxandrolone—Necrosis—Conjugated Estrogens—prostate cancer	0.000449	0.00733	CcSEcCtD
Oxandrolone—AR—lymph node—prostate cancer	0.000434	0.0248	CbGeAlD
Oxandrolone—Acne—Goserelin—prostate cancer	0.000422	0.0069	CcSEcCtD
Oxandrolone—Azoospermia—Doxorubicin—prostate cancer	0.000421	0.00687	CcSEcCtD
Oxandrolone—Fluid retention—Ethinyl Estradiol—prostate cancer	0.00041	0.0067	CcSEcCtD
Oxandrolone—Erectile dysfunction—Nilutamide—prostate cancer	0.000409	0.00668	CcSEcCtD
Oxandrolone—Erectile dysfunction—Flutamide—prostate cancer	0.000407	0.00665	CcSEcCtD
Oxandrolone—Jaundice cholestatic—Conjugated Estrogens—prostate cancer	0.000401	0.00655	CcSEcCtD
Oxandrolone—Neoplasm—Ethinyl Estradiol—prostate cancer	0.00039	0.00638	CcSEcCtD
Oxandrolone—Creatinine increased—Conjugated Estrogens—prostate cancer	0.00037	0.00604	CcSEcCtD
Oxandrolone—Erectile dysfunction—Degarelix—prostate cancer	0.000365	0.00597	CcSEcCtD
Oxandrolone—Trilostane—HSD3B2—prostate cancer	0.000361	0.114	CrCbGaD
Oxandrolone—Blood creatinine increased—Bicalutamide—prostate cancer	0.000347	0.00568	CcSEcCtD
Oxandrolone—Acne—Estradiol—prostate cancer	0.000335	0.00547	CcSEcCtD
Oxandrolone—Necrosis—Mitoxantrone—prostate cancer	0.000334	0.00547	CcSEcCtD
Oxandrolone—Fluid retention—Conjugated Estrogens—prostate cancer	0.000334	0.00546	CcSEcCtD
Oxandrolone—Menstruation irregular—Docetaxel—prostate cancer	0.000328	0.00536	CcSEcCtD
Oxandrolone—Neoplasm—Goserelin—prostate cancer	0.000321	0.00525	CcSEcCtD
Oxandrolone—Jaundice cholestatic—Estradiol—prostate cancer	0.000321	0.00524	CcSEcCtD
Oxandrolone—Neoplasm—Conjugated Estrogens—prostate cancer	0.000318	0.0052	CcSEcCtD
Oxandrolone—Gynaecomastia—Goserelin—prostate cancer	0.000318	0.0052	CcSEcCtD
Oxandrolone—Hirsutism—Capecitabine—prostate cancer	0.000302	0.00494	CcSEcCtD
Oxandrolone—Irritability—Ethinyl Estradiol—prostate cancer	0.000299	0.00489	CcSEcCtD
Oxandrolone—Erectile dysfunction—Bicalutamide—prostate cancer	0.000295	0.00482	CcSEcCtD
Oxandrolone—Oedema—Estramustine—prostate cancer	0.000285	0.00465	CcSEcCtD
Oxandrolone—Menstruation irregular—Prednisone—prostate cancer	0.000283	0.00462	CcSEcCtD
Oxandrolone—Necrosis—Etoposide—prostate cancer	0.000278	0.00455	CcSEcCtD
Oxandrolone—Oedema—Abiraterone—prostate cancer	0.000276	0.00452	CcSEcCtD
Oxandrolone—Oedema—Estrone—prostate cancer	0.000272	0.00444	CcSEcCtD
Oxandrolone—Hirsutism—Prednisone—prostate cancer	0.000269	0.0044	CcSEcCtD
Oxandrolone—Fluid retention—Estradiol—prostate cancer	0.000267	0.00437	CcSEcCtD
Oxandrolone—Haemoglobin—Bicalutamide—prostate cancer	0.000258	0.00421	CcSEcCtD
Oxandrolone—Insomnia—Estramustine—prostate cancer	0.000257	0.00421	CcSEcCtD
Oxandrolone—Haemorrhage—Bicalutamide—prostate cancer	0.000257	0.00419	CcSEcCtD
Oxandrolone—Neoplasm—Estradiol—prostate cancer	0.000255	0.00416	CcSEcCtD
Oxandrolone—Oedema—Nilutamide—prostate cancer	0.000252	0.00413	CcSEcCtD
Oxandrolone—Gynaecomastia—Estradiol—prostate cancer	0.000252	0.00412	CcSEcCtD
Oxandrolone—Oedema—Flutamide—prostate cancer	0.000251	0.00411	CcSEcCtD
Oxandrolone—Insomnia—Abiraterone—prostate cancer	0.00025	0.00408	CcSEcCtD
Oxandrolone—Irritability—Conjugated Estrogens—prostate cancer	0.000244	0.00399	CcSEcCtD
Oxandrolone—Blood creatinine increased—Conjugated Estrogens—prostate cancer	0.000239	0.00391	CcSEcCtD
Oxandrolone—Oedema—Estradiol valerate/Dienogest—prostate cancer	0.000237	0.00388	CcSEcCtD
Oxandrolone—Necrosis—Docetaxel—prostate cancer	0.000231	0.00378	CcSEcCtD
Oxandrolone—Insomnia—Nilutamide—prostate cancer	0.000228	0.00373	CcSEcCtD
Oxandrolone—Insomnia—Flutamide—prostate cancer	0.000227	0.00372	CcSEcCtD
Oxandrolone—Haemoglobin—Ethinyl Estradiol—prostate cancer	0.000218	0.00356	CcSEcCtD
Oxandrolone—Haemorrhage—Ethinyl Estradiol—prostate cancer	0.000217	0.00354	CcSEcCtD
Oxandrolone—Oedema—Cabazitaxel—prostate cancer	0.000212	0.00347	CcSEcCtD
Oxandrolone—Erectile dysfunction—Goserelin—prostate cancer	0.000205	0.00336	CcSEcCtD
Oxandrolone—Insomnia—Degarelix—prostate cancer	0.000204	0.00333	CcSEcCtD
Oxandrolone—AR—Regulation of Androgen receptor activity—NCOA2—prostate cancer	0.000203	0.00568	CbGpPWpGaD
Oxandrolone—Necrosis—Prednisone—prostate cancer	0.000199	0.00326	CcSEcCtD
Oxandrolone—AR—FOXA1 transcription factor network—BRCA1—prostate cancer	0.000196	0.00548	CbGpPWpGaD
Oxandrolone—Irritability—Estradiol—prostate cancer	0.000195	0.00319	CcSEcCtD
Oxandrolone—AR—Nuclear Receptors—VDR—prostate cancer	0.000193	0.00538	CbGpPWpGaD
Oxandrolone—AR—Nuclear Receptor transcription pathway—ESR2—prostate cancer	0.000192	0.00536	CbGpPWpGaD
Oxandrolone—AR—Notch-mediated HES/HEY network—NCOA1—prostate cancer	0.000189	0.00527	CbGpPWpGaD
Oxandrolone—Acne—Prednisone—prostate cancer	0.000186	0.00304	CcSEcCtD
Oxandrolone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MED12—prostate cancer	0.000183	0.00513	CbGpPWpGaD
Oxandrolone—Oedema—Bicalutamide—prostate cancer	0.000182	0.00298	CcSEcCtD
Oxandrolone—AR—Coregulation of Androgen receptor activity—NCOA2—prostate cancer	0.000182	0.00508	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—CD82—prostate cancer	0.000181	0.00507	CbGpPWpGaD
Oxandrolone—Haemoglobin—Goserelin—prostate cancer	0.000179	0.00293	CcSEcCtD
Oxandrolone—Blood creatinine increased—Mitoxantrone—prostate cancer	0.000179	0.00292	CcSEcCtD
Oxandrolone—Haemorrhage—Goserelin—prostate cancer	0.000178	0.00292	CcSEcCtD
Oxandrolone—AR—Regulation of nuclear SMAD2/3 signaling—ATF3—prostate cancer	0.000175	0.00488	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—DAG1—prostate cancer	0.000174	0.00486	CbGpPWpGaD
Oxandrolone—AR—Regulation of Androgen receptor activity—EGR1—prostate cancer	0.000174	0.00486	CbGpPWpGaD
Oxandrolone—AR—Nuclear Receptors—NR3C1—prostate cancer	0.000173	0.00485	CbGpPWpGaD
Oxandrolone—Fluid retention—Docetaxel—prostate cancer	0.000172	0.00282	CcSEcCtD
Oxandrolone—AR—Regulation of Androgen receptor activity—NCOA1—prostate cancer	0.000171	0.00479	CbGpPWpGaD
Oxandrolone—AR—Nuclear Receptor transcription pathway—RXRA—prostate cancer	0.000168	0.0047	CbGpPWpGaD
Oxandrolone—Fluid retention—Capecitabine—prostate cancer	0.000167	0.00273	CcSEcCtD
Oxandrolone—Insomnia—Bicalutamide—prostate cancer	0.000165	0.00269	CcSEcCtD
Oxandrolone—Neoplasm—Docetaxel—prostate cancer	0.000164	0.00268	CcSEcCtD
Oxandrolone—AR—Regulation of Androgen receptor activity—RXRA—prostate cancer	0.000163	0.00455	CbGpPWpGaD
Oxandrolone—AR—Nuclear Receptors—PPARA—prostate cancer	0.000162	0.00454	CbGpPWpGaD
Oxandrolone—AR—Androgen receptor signaling pathway—NCOA3—prostate cancer	0.000161	0.0045	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—RRAS—prostate cancer	0.000159	0.00445	CbGpPWpGaD
Oxandrolone—Neoplasm—Capecitabine—prostate cancer	0.000159	0.0026	CcSEcCtD
Oxandrolone—Necrosis—Epirubicin—prostate cancer	0.000156	0.00255	CcSEcCtD
Oxandrolone—Oedema—Ethinyl Estradiol—prostate cancer	0.000154	0.00252	CcSEcCtD
Oxandrolone—AR—Nuclear Receptor transcription pathway—VDR—prostate cancer	0.000152	0.00425	CbGpPWpGaD
Oxandrolone—Erectile dysfunction—Mitoxantrone—prostate cancer	0.000152	0.00248	CcSEcCtD
Oxandrolone—AR—Coregulation of Androgen receptor activity—BRCA1—prostate cancer	0.000151	0.00422	CbGpPWpGaD
Oxandrolone—AR—Regulation of Androgen receptor activity—SIRT1—prostate cancer	0.00015	0.00419	CbGpPWpGaD
Oxandrolone—Fluid retention—Prednisone—prostate cancer	0.000149	0.00243	CcSEcCtD
Oxandrolone—AR—Nuclear Receptors—ESR1—prostate cancer	0.000147	0.00411	CbGpPWpGaD
Oxandrolone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—NCOA2—prostate cancer	0.000146	0.00409	CbGpPWpGaD
Oxandrolone—Stanozolol—AR—prostate cancer	0.000145	0.0458	CrCbGaD
Oxandrolone—AR—Nongenotropic Androgen signaling—MAP2K1—prostate cancer	0.000145	0.00405	CbGpPWpGaD
Oxandrolone—AR—Regulation of nuclear SMAD2/3 signaling—NCOA2—prostate cancer	0.000145	0.00405	CbGpPWpGaD
Oxandrolone—Necrosis—Doxorubicin—prostate cancer	0.000144	0.00236	CcSEcCtD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—DAG1—prostate cancer	0.000144	0.00403	CbGpPWpGaD
Oxandrolone—AR—SIDS Susceptibility Pathways—HSP90B1—prostate cancer	0.000144	0.00403	CbGpPWpGaD
Oxandrolone—Haemoglobin—Estradiol—prostate cancer	0.000142	0.00232	CcSEcCtD
Oxandrolone—AR—Coregulation of Androgen receptor activity—VAV3—prostate cancer	0.000142	0.00396	CbGpPWpGaD
Oxandrolone—Haemorrhage—Estradiol—prostate cancer	0.000141	0.00231	CcSEcCtD
Oxandrolone—Jaundice cholestatic—Epirubicin—prostate cancer	0.000139	0.00228	CcSEcCtD
Oxandrolone—AR—Nuclear Receptor transcription pathway—NR3C1—prostate cancer	0.000137	0.00383	CbGpPWpGaD
Oxandrolone—AR—Androgen receptor signaling pathway—NCOA2—prostate cancer	0.000134	0.00375	CbGpPWpGaD
Oxandrolone—AR—Notch-mediated HES/HEY network—HIF1A—prostate cancer	0.000133	0.00372	CbGpPWpGaD
Oxandrolone—AR—Regulation of Androgen receptor activity—NR3C1—prostate cancer	0.000133	0.00371	CbGpPWpGaD
Oxandrolone—Haemoglobin—Mitoxantrone—prostate cancer	0.000133	0.00217	CcSEcCtD
Oxandrolone—AR—Androgen receptor signaling pathway—CALR—prostate cancer	0.000132	0.00369	CbGpPWpGaD
Oxandrolone—Haemorrhage—Mitoxantrone—prostate cancer	0.000132	0.00215	CcSEcCtD
Oxandrolone—AR—FOXA1 transcription factor network—ESR1—prostate cancer	0.000131	0.00366	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—STMN1—prostate cancer	0.000129	0.00361	CbGpPWpGaD
Oxandrolone—Jaundice cholestatic—Doxorubicin—prostate cancer	0.000129	0.00211	CcSEcCtD
Oxandrolone—Creatinine increased—Epirubicin—prostate cancer	0.000129	0.0021	CcSEcCtD
Oxandrolone—AR—Nuclear Receptor transcription pathway—PPARA—prostate cancer	0.000128	0.00359	CbGpPWpGaD
Oxandrolone—AR—Notch-mediated HES/HEY network—KDR—prostate cancer	0.000127	0.00356	CbGpPWpGaD
Oxandrolone—Oedema—Goserelin—prostate cancer	0.000127	0.00207	CcSEcCtD
Oxandrolone—Oedema—Conjugated Estrogens—prostate cancer	0.000126	0.00205	CcSEcCtD
Oxandrolone—AR—Generic Transcription Pathway—ZNF160—prostate cancer	0.000125	0.00349	CbGpPWpGaD
Oxandrolone—AR—Regulation of nuclear SMAD2/3 signaling—NCOA1—prostate cancer	0.000122	0.00341	CbGpPWpGaD
Oxandrolone—Irritability—Capecitabine—prostate cancer	0.000122	0.00199	CcSEcCtD
Oxandrolone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CCND2—prostate cancer	0.000121	0.0034	CbGpPWpGaD
Oxandrolone—Blood creatinine increased—Capecitabine—prostate cancer	0.000119	0.00195	CcSEcCtD
Oxandrolone—Creatinine increased—Doxorubicin—prostate cancer	0.000119	0.00194	CcSEcCtD
Oxandrolone—AR—FOXA1 transcription factor network—INS—prostate cancer	0.000117	0.00327	CbGpPWpGaD
Oxandrolone—AR—Nuclear Receptor transcription pathway—ESR1—prostate cancer	0.000116	0.00325	CbGpPWpGaD
Oxandrolone—Fluid retention—Epirubicin—prostate cancer	0.000116	0.0019	CcSEcCtD
Oxandrolone—AR—Integrated Breast Cancer Pathway—AHR—prostate cancer	0.000115	0.00322	CbGpPWpGaD
Oxandrolone—Insomnia—Goserelin—prostate cancer	0.000115	0.00187	CcSEcCtD
Oxandrolone—AR—FOXA1 transcription factor network—CREBBP—prostate cancer	0.000115	0.00321	CbGpPWpGaD
Oxandrolone—Trilostane—ESR2—prostate cancer	0.000114	0.036	CrCbGaD
Oxandrolone—Insomnia—Conjugated Estrogens—prostate cancer	0.000114	0.00186	CcSEcCtD
Oxandrolone—AR—Androgen receptor signaling pathway—NCOA1—prostate cancer	0.000113	0.00316	CbGpPWpGaD
Oxandrolone—AR—Androgen receptor signaling pathway—BRCA1—prostate cancer	0.000111	0.00312	CbGpPWpGaD
Oxandrolone—Neoplasm—Epirubicin—prostate cancer	0.000111	0.00181	CcSEcCtD
Oxandrolone—AR—Notch-mediated HES/HEY network—CREBBP—prostate cancer	0.000109	0.00304	CbGpPWpGaD
Oxandrolone—Irritability—Prednisone—prostate cancer	0.000108	0.00177	CcSEcCtD
Oxandrolone—Fluid retention—Doxorubicin—prostate cancer	0.000108	0.00176	CcSEcCtD
Oxandrolone—AR—Integrated Breast Cancer Pathway—NCOA3—prostate cancer	0.000105	0.00295	CbGpPWpGaD
Oxandrolone—AR—Regulation of nuclear SMAD2/3 signaling—VDR—prostate cancer	0.000105	0.00294	CbGpPWpGaD
Oxandrolone—Neoplasm—Doxorubicin—prostate cancer	0.000102	0.00167	CcSEcCtD
Oxandrolone—AR—Regulation of Androgen receptor activity—GSK3B—prostate cancer	0.000102	0.00286	CbGpPWpGaD
Oxandrolone—AR—Regulation of nuclear SMAD2/3 signaling—IL10—prostate cancer	0.000102	0.00286	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—HSP90AB1—prostate cancer	0.000102	0.00285	CbGpPWpGaD
Oxandrolone—Oedema—Estradiol—prostate cancer	0.000101	0.00164	CcSEcCtD
Oxandrolone—AR—Nongenotropic Androgen signaling—SRC—prostate cancer	0.0001	0.00281	CbGpPWpGaD
Oxandrolone—Drostanolone—SHBG—prostate cancer	9.92e-05	0.0313	CrCbGaD
Oxandrolone—AR—Androgen receptor signaling pathway—SIRT1—prostate cancer	9.89e-05	0.00276	CbGpPWpGaD
Oxandrolone—AR—Regulation of Androgen receptor activity—CREBBP—prostate cancer	9.88e-05	0.00276	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—EIF2AK2—prostate cancer	9.8e-05	0.00274	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—TGFBR1—prostate cancer	9.53e-05	0.00266	CbGpPWpGaD
Oxandrolone—AR—Notch-mediated HES/HEY network—JAK2—prostate cancer	9.46e-05	0.00265	CbGpPWpGaD
Oxandrolone—AR—Regulation of nuclear SMAD2/3 signaling—NR3C1—prostate cancer	9.46e-05	0.00264	CbGpPWpGaD
Oxandrolone—Oedema—Mitoxantrone—prostate cancer	9.37e-05	0.00153	CcSEcCtD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—WT1—prostate cancer	9.29e-05	0.0026	CbGpPWpGaD
Oxandrolone—Haemoglobin—Docetaxel—prostate cancer	9.16e-05	0.0015	CcSEcCtD
Oxandrolone—Haemorrhage—Docetaxel—prostate cancer	9.11e-05	0.00149	CcSEcCtD
Oxandrolone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—TERT—prostate cancer	9.1e-05	0.00254	CbGpPWpGaD
Oxandrolone—Insomnia—Estradiol—prostate cancer	9.09e-05	0.00149	CcSEcCtD
Oxandrolone—AR—SIDS Susceptibility Pathways—PRKACB—prostate cancer	9.09e-05	0.00254	CbGpPWpGaD
Oxandrolone—Erectile dysfunction—Prednisone—prostate cancer	9.04e-05	0.00148	CcSEcCtD
Oxandrolone—AR—Integrated Breast Cancer Pathway—ANXA1—prostate cancer	8.96e-05	0.00251	CbGpPWpGaD
Oxandrolone—AR—FOXA1 transcription factor network—CDKN1B—prostate cancer	8.89e-05	0.00249	CbGpPWpGaD
Oxandrolone—Haemoglobin—Capecitabine—prostate cancer	8.87e-05	0.00145	CcSEcCtD
Oxandrolone—Haemorrhage—Capecitabine—prostate cancer	8.82e-05	0.00144	CcSEcCtD
Oxandrolone—Testosterone Propionate—CYP17A1—prostate cancer	8.73e-05	0.0276	CrCbGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—AURKA—prostate cancer	8.72e-05	0.00244	CbGpPWpGaD
Oxandrolone—Drostanolone—AR—prostate cancer	8.7e-05	0.0275	CrCbGaD
Oxandrolone—AR—Generic Transcription Pathway—TBX5—prostate cancer	8.64e-05	0.00242	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—GADD45A—prostate cancer	8.53e-05	0.00239	CbGpPWpGaD
Oxandrolone—AR—SIDS Susceptibility Pathways—IL1RN—prostate cancer	8.45e-05	0.00236	CbGpPWpGaD
Oxandrolone—AR—Notch-mediated HES/HEY network—CDKN1B—prostate cancer	8.44e-05	0.00236	CbGpPWpGaD
Oxandrolone—AR—Regulation of Androgen receptor activity—MDM2—prostate cancer	8.39e-05	0.00235	CbGpPWpGaD
Oxandrolone—Testosterone—CYP3A43—prostate cancer	8.34e-05	0.0263	CrCbGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—HPGDS—prostate cancer	8.33e-05	0.00233	CbGpPWpGaD
Oxandrolone—Blood creatinine increased—Epirubicin—prostate cancer	8.32e-05	0.00136	CcSEcCtD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—IGFBP3—prostate cancer	8.28e-05	0.00231	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—ACHE—prostate cancer	8.08e-05	0.00226	CbGpPWpGaD
Oxandrolone—AR—Regulation of nuclear SMAD2/3 signaling—ESR1—prostate cancer	8.03e-05	0.00225	CbGpPWpGaD
Oxandrolone—Haemoglobin—Prednisone—prostate cancer	7.9e-05	0.00129	CcSEcCtD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—TGFBR1—prostate cancer	7.9e-05	0.00221	CbGpPWpGaD
Oxandrolone—Haemorrhage—Prednisone—prostate cancer	7.86e-05	0.00128	CcSEcCtD
Oxandrolone—AR—SIDS Susceptibility Pathways—ESR2—prostate cancer	7.84e-05	0.00219	CbGpPWpGaD
Oxandrolone—AR—FOXA1 transcription factor network—EP300—prostate cancer	7.81e-05	0.00218	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—CHEK2—prostate cancer	7.79e-05	0.00218	CbGpPWpGaD
Oxandrolone—AR—SIDS Susceptibility Pathways—TH—prostate cancer	7.78e-05	0.00218	CbGpPWpGaD
Oxandrolone—AR—Androgen receptor signaling pathway—CAV1—prostate cancer	7.73e-05	0.00216	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—CASP9—prostate cancer	7.72e-05	0.00216	CbGpPWpGaD
Oxandrolone—Blood creatinine increased—Doxorubicin—prostate cancer	7.7e-05	0.00126	CcSEcCtD
Oxandrolone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—APC—prostate cancer	7.67e-05	0.00214	CbGpPWpGaD
Oxandrolone—AR—Nongenotropic Androgen signaling—PIK3CA—prostate cancer	7.64e-05	0.00214	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—TOP2A—prostate cancer	7.57e-05	0.00212	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—THBS1—prostate cancer	7.53e-05	0.00211	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—ANXA1—prostate cancer	7.42e-05	0.00208	CbGpPWpGaD
Oxandrolone—AR—Notch-mediated HES/HEY network—EP300—prostate cancer	7.41e-05	0.00207	CbGpPWpGaD
Oxandrolone—AR—SIDS Susceptibility Pathways—EGR1—prostate cancer	7.33e-05	0.00205	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—CYP19A1—prostate cancer	7.3e-05	0.00204	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—BRCA1—prostate cancer	7.3e-05	0.00204	CbGpPWpGaD
Oxandrolone—Drostanolone—CYP19A1—prostate cancer	7.28e-05	0.023	CrCbGaD
Oxandrolone—Allylestrenol—ESR1—prostate cancer	7.21e-05	0.0228	CrCbGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—EZH2—prostate cancer	7.19e-05	0.00201	CbGpPWpGaD
Oxandrolone—Testosterone Propionate—COMT—prostate cancer	7.11e-05	0.0225	CrCbGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—GADD45A—prostate cancer	7.07e-05	0.00198	CbGpPWpGaD
Oxandrolone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDH1—prostate cancer	7.05e-05	0.00197	CbGpPWpGaD
Oxandrolone—AR—Regulation of nuclear SMAD2/3 signaling—CREBBP—prostate cancer	7.04e-05	0.00197	CbGpPWpGaD
Oxandrolone—Trilostane—ESR1—prostate cancer	7.02e-05	0.0222	CrCbGaD
Oxandrolone—AR—SIDS Susceptibility Pathways—GJA1—prostate cancer	6.98e-05	0.00195	CbGpPWpGaD
Oxandrolone—AR—Notch-mediated HES/HEY network—STAT3—prostate cancer	6.95e-05	0.00194	CbGpPWpGaD
Oxandrolone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP2—prostate cancer	6.79e-05	0.0019	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—TGFBR2—prostate cancer	6.76e-05	0.00189	CbGpPWpGaD
Oxandrolone—AR—Androgen receptor signaling pathway—GSK3B—prostate cancer	6.75e-05	0.00189	CbGpPWpGaD
Oxandrolone—AR—Regulation of Androgen receptor activity—EP300—prostate cancer	6.73e-05	0.00188	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—ESR2—prostate cancer	6.66e-05	0.00186	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—BRCA2—prostate cancer	6.61e-05	0.00185	CbGpPWpGaD
Oxandrolone—AR—Regulation of nuclear SMAD2/3 signaling—SERPINE1—prostate cancer	6.6e-05	0.00185	CbGpPWpGaD
Oxandrolone—AR—Regulation of Androgen receptor activity—SRC—prostate cancer	6.54e-05	0.00183	CbGpPWpGaD
Oxandrolone—AR—Coregulation of Androgen receptor activity—CCND1—prostate cancer	6.53e-05	0.00183	CbGpPWpGaD
Oxandrolone—AR—Androgen receptor signaling pathway—CREBBP—prostate cancer	6.53e-05	0.00182	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—SIRT1—prostate cancer	6.48e-05	0.00181	CbGpPWpGaD
Oxandrolone—Oedema—Docetaxel—prostate cancer	6.47e-05	0.00106	CcSEcCtD
Oxandrolone—AR—Coregulation of Androgen receptor activity—CTNNB1—prostate cancer	6.47e-05	0.00181	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—CHEK2—prostate cancer	6.46e-05	0.00181	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—CASP9—prostate cancer	6.39e-05	0.00179	CbGpPWpGaD
Oxandrolone—Oedema—Capecitabine—prostate cancer	6.27e-05	0.00102	CcSEcCtD
Oxandrolone—AR—Nongenotropic Androgen signaling—AKT1—prostate cancer	6.24e-05	0.00175	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—EGR1—prostate cancer	6.23e-05	0.00174	CbGpPWpGaD
Oxandrolone—Haemoglobin—Epirubicin—prostate cancer	6.18e-05	0.00101	CcSEcCtD
Oxandrolone—Haemorrhage—Epirubicin—prostate cancer	6.15e-05	0.001	CcSEcCtD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—BRCA1—prostate cancer	6.05e-05	0.00169	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—BAX—prostate cancer	6.05e-05	0.00169	CbGpPWpGaD
Oxandrolone—AR—SIDS Susceptibility Pathways—IL10—prostate cancer	6.05e-05	0.00169	CbGpPWpGaD
Oxandrolone—AR—Gene Expression—SSR2—prostate cancer	6e-05	0.00168	CbGpPWpGaD
Oxandrolone—AR—Gene Expression—ZNF160—prostate cancer	6e-05	0.00168	CbGpPWpGaD
Oxandrolone—AR—Gene Expression—BAZ2A—prostate cancer	6e-05	0.00168	CbGpPWpGaD
Oxandrolone—Insomnia—Docetaxel—prostate cancer	5.86e-05	0.000957	CcSEcCtD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—RXRA—prostate cancer	5.84e-05	0.00163	CbGpPWpGaD
Oxandrolone—Haemoglobin—Doxorubicin—prostate cancer	5.72e-05	0.000934	CcSEcCtD
Oxandrolone—Haemorrhage—Doxorubicin—prostate cancer	5.69e-05	0.000929	CcSEcCtD
Oxandrolone—Insomnia—Capecitabine—prostate cancer	5.67e-05	0.000926	CcSEcCtD
Oxandrolone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CXCL8—prostate cancer	5.64e-05	0.00158	CbGpPWpGaD
Oxandrolone—Fluoxymesterone—SHBG—prostate cancer	5.61e-05	0.0177	CrCbGaD
Oxandrolone—AR—SIDS Susceptibility Pathways—NR3C1—prostate cancer	5.6e-05	0.00157	CbGpPWpGaD
Oxandrolone—Oedema—Prednisone—prostate cancer	5.58e-05	0.000912	CcSEcCtD
Oxandrolone—AR—Androgen receptor signaling pathway—MDM2—prostate cancer	5.54e-05	0.00155	CbGpPWpGaD
Oxandrolone—AR—Gene Expression—HNRNPH1—prostate cancer	5.49e-05	0.00153	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—BRCA2—prostate cancer	5.47e-05	0.00153	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—SIRT1—prostate cancer	5.37e-05	0.0015	CbGpPWpGaD
Oxandrolone—Danazol—SHBG—prostate cancer	5.36e-05	0.0169	CrCbGaD
Oxandrolone—Testosterone Propionate—AR—prostate cancer	5.3e-05	0.0167	CrCbGaD
Oxandrolone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CCND1—prostate cancer	5.26e-05	0.00147	CbGpPWpGaD
Oxandrolone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CTNNB1—prostate cancer	5.21e-05	0.00146	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—TYMS—prostate cancer	5.21e-05	0.00146	CbGpPWpGaD
Oxandrolone—Spironolactone—SHBG—prostate cancer	5.13e-05	0.0162	CrCbGaD
Oxandrolone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP9—prostate cancer	5.11e-05	0.00143	CbGpPWpGaD
Oxandrolone—AR—Gene Expression—NFIC—prostate cancer	5.1e-05	0.00143	CbGpPWpGaD
Oxandrolone—AR—SIDS Susceptibility Pathways—HIF1A—prostate cancer	5.1e-05	0.00143	CbGpPWpGaD
Oxandrolone—Insomnia—Prednisone—prostate cancer	5.05e-05	0.000825	CcSEcCtD
Oxandrolone—AR—Regulation of nuclear SMAD2/3 signaling—CDKN1A—prostate cancer	5.04e-05	0.00141	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—BAX—prostate cancer	5.01e-05	0.0014	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—ATM—prostate cancer	4.92e-05	0.00138	CbGpPWpGaD
Oxandrolone—Fluoxymesterone—AR—prostate cancer	4.92e-05	0.0155	CrCbGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—ESR1—prostate cancer	4.88e-05	0.00136	CbGpPWpGaD
Oxandrolone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—EP300—prostate cancer	4.84e-05	0.00135	CbGpPWpGaD
Oxandrolone—AR—Androgen receptor signaling pathway—CCND1—prostate cancer	4.83e-05	0.00135	CbGpPWpGaD
Oxandrolone—AR—Gene Expression—RPN2—prostate cancer	4.8e-05	0.00134	CbGpPWpGaD
Oxandrolone—AR—Regulation of nuclear SMAD2/3 signaling—EP300—prostate cancer	4.79e-05	0.00134	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—FASLG—prostate cancer	4.78e-05	0.00134	CbGpPWpGaD
Oxandrolone—AR—Androgen receptor signaling pathway—CTNNB1—prostate cancer	4.78e-05	0.00134	CbGpPWpGaD
Oxandrolone—Norethindrone—SHBG—prostate cancer	4.77e-05	0.015	CrCbGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—BAD—prostate cancer	4.76e-05	0.00133	CbGpPWpGaD
Oxandrolone—Danazol—AR—prostate cancer	4.7e-05	0.0148	CrCbGaD
Oxandrolone—AR—Androgen receptor signaling pathway—CDKN1A—prostate cancer	4.67e-05	0.00131	CbGpPWpGaD
Oxandrolone—AR—Androgen receptor signaling pathway—PTEN—prostate cancer	4.66e-05	0.0013	CbGpPWpGaD
Oxandrolone—AR—Generic Transcription Pathway—NPPA—prostate cancer	4.61e-05	0.00129	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—IRS1—prostate cancer	4.56e-05	0.00127	CbGpPWpGaD
Oxandrolone—AR—Gene Expression—QARS—prostate cancer	4.55e-05	0.00127	CbGpPWpGaD
Oxandrolone—AR—Generic Transcription Pathway—MED12—prostate cancer	4.54e-05	0.00127	CbGpPWpGaD
Oxandrolone—Methyltestosterone—SHBG—prostate cancer	4.53e-05	0.0143	CrCbGaD
Oxandrolone—Spironolactone—AR—prostate cancer	4.5e-05	0.0142	CrCbGaD
Oxandrolone—AR—Androgen receptor signaling pathway—EP300—prostate cancer	4.44e-05	0.00124	CbGpPWpGaD
Oxandrolone—Oedema—Epirubicin—prostate cancer	4.37e-05	0.000714	CcSEcCtD
Oxandrolone—AR—Androgen receptor signaling pathway—SRC—prostate cancer	4.32e-05	0.00121	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—CDH1—prostate cancer	4.24e-05	0.00119	CbGpPWpGaD
Oxandrolone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MYC—prostate cancer	4.22e-05	0.00118	CbGpPWpGaD
Oxandrolone—AR—Regulation of nuclear SMAD2/3 signaling—MYC—prostate cancer	4.18e-05	0.00117	CbGpPWpGaD
Oxandrolone—AR—Androgen receptor signaling pathway—STAT3—prostate cancer	4.17e-05	0.00117	CbGpPWpGaD
Oxandrolone—AR—SIDS Susceptibility Pathways—CREBBP—prostate cancer	4.17e-05	0.00116	CbGpPWpGaD
Oxandrolone—AR—Gene Expression—TBX5—prostate cancer	4.16e-05	0.00116	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—ATM—prostate cancer	4.08e-05	0.00114	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—ESR1—prostate cancer	4.04e-05	0.00113	CbGpPWpGaD
Oxandrolone—Oedema—Doxorubicin—prostate cancer	4.04e-05	0.00066	CcSEcCtD
Oxandrolone—Progesterone—CYP17A1—prostate cancer	4.01e-05	0.0127	CrCbGaD
Oxandrolone—Methyltestosterone—AR—prostate cancer	3.97e-05	0.0125	CrCbGaD
Oxandrolone—Insomnia—Epirubicin—prostate cancer	3.95e-05	0.000645	CcSEcCtD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—BAD—prostate cancer	3.95e-05	0.0011	CbGpPWpGaD
Oxandrolone—Danazol—CYP19A1—prostate cancer	3.93e-05	0.0124	CrCbGaD
Oxandrolone—AR—Gene Expression—EIF3H—prostate cancer	3.87e-05	0.00108	CbGpPWpGaD
Oxandrolone—Progesterone—SLC22A3—prostate cancer	3.82e-05	0.0121	CrCbGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—APC—prostate cancer	3.82e-05	0.00107	CbGpPWpGaD
Oxandrolone—Norethindrone—CYP3A5—prostate cancer	3.8e-05	0.012	CrCbGaD
Oxandrolone—AR—Androgen receptor signaling pathway—EGFR—prostate cancer	3.79e-05	0.00106	CbGpPWpGaD
Oxandrolone—Fluoxymesterone—ESR1—prostate cancer	3.79e-05	0.012	CrCbGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—EGF—prostate cancer	3.78e-05	0.00106	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—BCL2—prostate cancer	3.69e-05	0.00103	CbGpPWpGaD
Oxandrolone—Allylestrenol—CYP3A4—prostate cancer	3.68e-05	0.0116	CrCbGaD
Oxandrolone—Insomnia—Doxorubicin—prostate cancer	3.65e-05	0.000597	CcSEcCtD
Oxandrolone—AR—Coregulation of Androgen receptor activity—AKT1—prostate cancer	3.63e-05	0.00102	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—MDM2—prostate cancer	3.63e-05	0.00102	CbGpPWpGaD
Oxandrolone—AR—Generic Transcription Pathway—NCOA2—prostate cancer	3.62e-05	0.00101	CbGpPWpGaD
Oxandrolone—Danazol—ESR1—prostate cancer	3.62e-05	0.0114	CrCbGaD
Oxandrolone—Testosterone—SLC22A3—prostate cancer	3.61e-05	0.0114	CrCbGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—CREBBP—prostate cancer	3.54e-05	0.000991	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—IGF1—prostate cancer	3.5e-05	0.000978	CbGpPWpGaD
Oxandrolone—AR—Generic Transcription Pathway—PARP1—prostate cancer	3.5e-05	0.000978	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—MAP2K1—prostate cancer	3.38e-05	0.000946	CbGpPWpGaD
Oxandrolone—Fluoxymesterone—NR3C1—prostate cancer	3.33e-05	0.0105	CrCbGaD
Oxandrolone—Methyltestosterone—CYP19A1—prostate cancer	3.32e-05	0.0105	CrCbGaD
Oxandrolone—AR—Generic Transcription Pathway—ESR2—prostate cancer	3.31e-05	0.000926	CbGpPWpGaD
Oxandrolone—AR—SIDS Susceptibility Pathways—CXCL8—prostate cancer	3.31e-05	0.000925	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—CASP3—prostate cancer	3.25e-05	0.000909	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—FGF2—prostate cancer	3.22e-05	0.000899	CbGpPWpGaD
Oxandrolone—AR—SIDS Susceptibility Pathways—CASP3—prostate cancer	3.17e-05	0.000885	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—CCND1—prostate cancer	3.16e-05	0.000885	CbGpPWpGaD
Oxandrolone—AR—Gene Expression—TET2—prostate cancer	3.15e-05	0.000882	CbGpPWpGaD
Oxandrolone—AR—Gene Expression—MBD2—prostate cancer	3.15e-05	0.000882	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—CTNNB1—prostate cancer	3.13e-05	0.000876	CbGpPWpGaD
Oxandrolone—AR—Gene Expression—RPL12—prostate cancer	3.09e-05	0.000864	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—BCL2—prostate cancer	3.05e-05	0.000854	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—PTEN—prostate cancer	3.05e-05	0.000854	CbGpPWpGaD
Oxandrolone—Spironolactone—NR3C1—prostate cancer	3.05e-05	0.00964	CrCbGaD
Oxandrolone—AR—SIDS Susceptibility Pathways—CTNNB1—prostate cancer	3.05e-05	0.000853	CbGpPWpGaD
Oxandrolone—AR—Generic Transcription Pathway—NCOA1—prostate cancer	3.05e-05	0.000853	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—MDM2—prostate cancer	3.01e-05	0.000842	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—ERBB2—prostate cancer	2.97e-05	0.00083	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—EP300—prostate cancer	2.91e-05	0.000814	CbGpPWpGaD
Oxandrolone—AR—Generic Transcription Pathway—RXRA—prostate cancer	2.9e-05	0.000811	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—PTGS2—prostate cancer	2.9e-05	0.000811	CbGpPWpGaD
Oxandrolone—AR—Regulation of nuclear SMAD2/3 signaling—AKT1—prostate cancer	2.9e-05	0.00081	CbGpPWpGaD
Oxandrolone—AR—Gene Expression—EIF3A—prostate cancer	2.84e-05	0.000794	CbGpPWpGaD
Oxandrolone—AR—SIDS Susceptibility Pathways—EP300—prostate cancer	2.84e-05	0.000793	CbGpPWpGaD
Oxandrolone—Progesterone—SHBG—prostate cancer	2.78e-05	0.00877	CrCbGaD
Oxandrolone—Progesterone—CYP1B1—prostate cancer	2.78e-05	0.00877	CrCbGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—VEGFA—prostate cancer	2.76e-05	0.000771	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—CDKN1B—prostate cancer	2.75e-05	0.000768	CbGpPWpGaD
Oxandrolone—Progesterone—SLC22A1—prostate cancer	2.74e-05	0.00865	CrCbGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—CASP3—prostate cancer	2.69e-05	0.000753	CbGpPWpGaD
Oxandrolone—AR—SIDS Susceptibility Pathways—VEGFA—prostate cancer	2.69e-05	0.000751	CbGpPWpGaD
Oxandrolone—AR—Androgen receptor signaling pathway—AKT1—prostate cancer	2.69e-05	0.000751	CbGpPWpGaD
Oxandrolone—AR—Generic Transcription Pathway—VDR—prostate cancer	2.63e-05	0.000735	CbGpPWpGaD
Oxandrolone—Testosterone—SHBG—prostate cancer	2.63e-05	0.00829	CrCbGaD
Oxandrolone—Testosterone—CYP1B1—prostate cancer	2.63e-05	0.00829	CrCbGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—CCND1—prostate cancer	2.62e-05	0.000733	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—CTNNB1—prostate cancer	2.6e-05	0.000726	CbGpPWpGaD
Oxandrolone—Testosterone—SLC22A1—prostate cancer	2.59e-05	0.00818	CrCbGaD
Oxandrolone—Norethindrone—CYP2C19—prostate cancer	2.58e-05	0.00816	CrCbGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—MYC—prostate cancer	2.54e-05	0.00071	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—CDKN1A—prostate cancer	2.54e-05	0.000709	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—PTEN—prostate cancer	2.53e-05	0.000707	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—EGFR—prostate cancer	2.48e-05	0.000694	CbGpPWpGaD
Oxandrolone—Progesterone—AR—prostate cancer	2.44e-05	0.00769	CrCbGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—EP300—prostate cancer	2.41e-05	0.000675	CbGpPWpGaD
Oxandrolone—AR—Gene Expression—DNMT3B—prostate cancer	2.39e-05	0.000668	CbGpPWpGaD
Oxandrolone—AR—Generic Transcription Pathway—NR3C1—prostate cancer	2.37e-05	0.000661	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—SRC—prostate cancer	2.35e-05	0.000656	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—KRAS—prostate cancer	2.34e-05	0.000656	CbGpPWpGaD
Oxandrolone—AR—Gene Expression—RPL10—prostate cancer	2.34e-05	0.000655	CbGpPWpGaD
Oxandrolone—Testosterone—AR—prostate cancer	2.3e-05	0.00727	CrCbGaD
Oxandrolone—AR—Gene Expression—HIST1H2BG—prostate cancer	2.3e-05	0.000643	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—VEGFA—prostate cancer	2.29e-05	0.000639	CbGpPWpGaD
Oxandrolone—AR—Gene Expression—HIST1H4H—prostate cancer	2.22e-05	0.000621	CbGpPWpGaD
Oxandrolone—AR—Gene Expression—NPPA—prostate cancer	2.22e-05	0.000621	CbGpPWpGaD
Oxandrolone—AR—Generic Transcription Pathway—PPARA—prostate cancer	2.22e-05	0.00062	CbGpPWpGaD
Oxandrolone—Progesterone—CYP3A5—prostate cancer	2.21e-05	0.00698	CrCbGaD
Oxandrolone—AR—Gene Expression—MED12—prostate cancer	2.19e-05	0.000611	CbGpPWpGaD
Oxandrolone—Progesterone—CYP2A6—prostate cancer	2.14e-05	0.00676	CrCbGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—MYC—prostate cancer	2.1e-05	0.000588	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—TGFB1—prostate cancer	2.1e-05	0.000587	CbGpPWpGaD
Oxandrolone—Testosterone—CYP3A5—prostate cancer	2.09e-05	0.0066	CrCbGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—TP53—prostate cancer	2.08e-05	0.000583	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—EGFR—prostate cancer	2.06e-05	0.000575	CbGpPWpGaD
Oxandrolone—AR—Generic Transcription Pathway—ESR1—prostate cancer	2.01e-05	0.000562	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—KRAS—prostate cancer	1.94e-05	0.000543	CbGpPWpGaD
Oxandrolone—Testosterone—CYP19A1—prostate cancer	1.93e-05	0.00608	CrCbGaD
Oxandrolone—Progesterone—ESR1—prostate cancer	1.88e-05	0.00592	CrCbGaD
Oxandrolone—AR—SIDS Susceptibility Pathways—IL6—prostate cancer	1.86e-05	0.00052	CbGpPWpGaD
Oxandrolone—AR—Gene Expression—RPS19—prostate cancer	1.86e-05	0.00052	CbGpPWpGaD
Oxandrolone—Danazol—CYP3A4—prostate cancer	1.85e-05	0.00583	CrCbGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—PIK3CA—prostate cancer	1.78e-05	0.000499	CbGpPWpGaD
Oxandrolone—AR—Gene Expression—DNMT1—prostate cancer	1.78e-05	0.000497	CbGpPWpGaD
Oxandrolone—AR—Generic Transcription Pathway—CREBBP—prostate cancer	1.76e-05	0.000492	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—AKT1—prostate cancer	1.76e-05	0.000492	CbGpPWpGaD
Oxandrolone—AR—Gene Expression—NCOA2—prostate cancer	1.74e-05	0.000487	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—TP53—prostate cancer	1.73e-05	0.000483	CbGpPWpGaD
Oxandrolone—AR—Gene Expression—EZH2—prostate cancer	1.72e-05	0.000481	CbGpPWpGaD
Oxandrolone—AR—Gene Expression—PARP1—prostate cancer	1.68e-05	0.000471	CbGpPWpGaD
Oxandrolone—Progesterone—NR3C1—prostate cancer	1.65e-05	0.00521	CrCbGaD
Oxandrolone—AR—Generic Transcription Pathway—SERPINE1—prostate cancer	1.65e-05	0.000462	CbGpPWpGaD
Oxandrolone—Norethindrone—CYP3A4—prostate cancer	1.64e-05	0.00519	CrCbGaD
Oxandrolone—AR—Gene Expression—HSPA1A—prostate cancer	1.59e-05	0.000446	CbGpPWpGaD
Oxandrolone—AR—Gene Expression—ESR2—prostate cancer	1.59e-05	0.000446	CbGpPWpGaD
Oxandrolone—Methyltestosterone—CYP3A4—prostate cancer	1.56e-05	0.00493	CrCbGaD
Oxandrolone—Progesterone—CYP2C19—prostate cancer	1.51e-05	0.00475	CrCbGaD
Oxandrolone—Progesterone—CYP1A1—prostate cancer	1.5e-05	0.00474	CrCbGaD
Oxandrolone—AR—Gene Expression—NCOA1—prostate cancer	1.47e-05	0.000411	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—AKT1—prostate cancer	1.46e-05	0.000408	CbGpPWpGaD
Oxandrolone—Testosterone—CYP2C19—prostate cancer	1.42e-05	0.00449	CrCbGaD
Oxandrolone—Testosterone—CYP1A1—prostate cancer	1.42e-05	0.00448	CrCbGaD
Oxandrolone—AR—Gene Expression—RXRA—prostate cancer	1.4e-05	0.000391	CbGpPWpGaD
Oxandrolone—AR—Gene Expression—SIRT1—prostate cancer	1.28e-05	0.000359	CbGpPWpGaD
Oxandrolone—AR—Gene Expression—VDR—prostate cancer	1.27e-05	0.000354	CbGpPWpGaD
Oxandrolone—AR—Gene Expression—ERCC2—prostate cancer	1.16e-05	0.000324	CbGpPWpGaD
Oxandrolone—AR—Gene Expression—NR3C1—prostate cancer	1.14e-05	0.000318	CbGpPWpGaD
Oxandrolone—AR—Gene Expression—PPARA—prostate cancer	1.07e-05	0.000298	CbGpPWpGaD
Oxandrolone—AR—Generic Transcription Pathway—MYC—prostate cancer	1.04e-05	0.000292	CbGpPWpGaD
Oxandrolone—AR—Gene Expression—ESR1—prostate cancer	9.67e-06	0.00027	CbGpPWpGaD
Oxandrolone—Progesterone—CYP3A4—prostate cancer	9.57e-06	0.00302	CrCbGaD
Oxandrolone—Testosterone—CYP3A4—prostate cancer	9.05e-06	0.00286	CrCbGaD
Oxandrolone—AR—Gene Expression—CREBBP—prostate cancer	8.47e-06	0.000237	CbGpPWpGaD
Oxandrolone—AR—Gene Expression—SERPINE1—prostate cancer	7.95e-06	0.000222	CbGpPWpGaD
Oxandrolone—AR—Gene Expression—MYC—prostate cancer	5.03e-06	0.000141	CbGpPWpGaD
Oxandrolone—AR—Gene Expression—AKT1—prostate cancer	3.49e-06	9.75e-05	CbGpPWpGaD
